Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGENUS INCAGEN · Entity 5774 | Director | October 01, 2024 | October 03, 2024 |
| MiNK Therapeutics, Inc.INKT · Entity 52 | Director | September 01, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGENUS INC
Report date October 01, 2024 · Filed October 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,500.664 |
Reported balance
After 2024-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-01 · Grant · Acquired 3,423.478 · Balance 19,500.664 F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3: $7.49 per Deferred Stock Unit acquired on October 1, 2024. The price of each Deferred Stock Unit acquired on October 1,2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3: $7.49 per Deferred Stock Unit acquired on October 1, 2024. The price of each Deferred Stock Unit acquired on October 1,2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.
MiNK Therapeutics, Inc.
Report date September 01, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,929 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 1,279 · Balance 23,929 F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 27,830 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 27,830 F2: Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2: Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2020 Filed Jun 17, 2020 21:07 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 16,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001745285-20-000014 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,191 Underlying: Common Stock · 16,853 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award fully vests on June 16, 2021. F1 · derivative.expiration_date: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award fully vests on June 16, 2021. F2 · balance_after: Includes 20,338 Restricted Stock Units that are scheduled to vest on June 19, 2020. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 18:33 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 8,009.024 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000002 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,419.829 Underlying: Common Stock · 8,009.024 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.200 per Deferred Stock Unit acquired on April 1, 2020. The price of each Deferred Stock Unit acquired prior to April 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:19 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 5,667.535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-000608 · doc4.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,410.805 Underlying: Common Stock · 5,667.535 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.419 per Deferred Stock Unit acquired on January 2, 2020. The price of each Deferred Stock Unit acquired prior to January 2, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| December 24, 2019 Filed Dec 27, 2019 20:34 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 75,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-19-030104 · doc4.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-12-24 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on December 24, 2020. Read SEC document |
| October 01, 2019 Filed Oct 1, 2019 19:11 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 7,107.239 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-19-000015 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,743.27 Underlying: Common Stock · 7,107.239 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.726 per Deferred Stock Unit acquired on October 1, 2019. The price of each Deferred Stock Unit acquired prior to October 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 10:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,961.078 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-018767 · doc4.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,636.031 Underlying: Common Stock · 6,961.078 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.783 per Deferred Stock Unit acquired on July 1, 2019. The price of each Deferred Stock Unit acquired prior to July 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:23 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-017827 · doc4.xml · derivative · entry 2 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,338 Underlying: Common Stock · 20,338 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. F2 · price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. F2 · derivative.expiration_date: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:23 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option, Right to buy · Derivative | 100,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0000899243-19-017827 · doc4.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Option was granted on January 1, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan. The option vests on January 1, 2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:57 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,129.421 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-19-000005 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,674.953 Underlying: Common Stock · 6,129.421 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.161 per Deferred Stock Unit acquired on April 1, 2019. The price of each Deferred Stock Unit acquired prior to April 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:59 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 7,940.88 | $2.13 Strike: $2.13 | $16,874.37 |
DisclosureSEC source: 0001745285-19-000002 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940.88 Underlying: Common Stock · 7,940.88 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 19:31 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 8,416.126 | $2.01 Strike: $2.01 | $16,874.33 |
DisclosureSEC source: 0001288123-18-000025 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,416.126 Underlying: Common Stock · 8,416.126 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 19:27 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 4,913.781 | $3.43 Strike: $3.43 | $16,873.92 |
DisclosureSEC source: 0001288123-18-000020 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913.781 Underlying: Common Stock · 4,913.781 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 16:43 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 15,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001288123-18-000017 · primary_doc.xml · derivative · entry 2 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,957 Underlying: Common Stock · 15,957 shares Expires 2028-04-19 F2 · derivative.exercise_price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019. F2 · price: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019. F2 · derivative.exercise_date: RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 16:43 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option, right to buy · Derivative | 37,500 | $5.65 Strike: $5.65 | $211,875.00 |
DisclosureSEC source: 0001288123-18-000017 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2028-03-02 F1 · derivative.exercise_date: Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 20:13 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 3,728.539 | $4.53 Strike: $4.53 | $16,875.37 |
DisclosureSEC source: 0000899243-18-009223 · doc4.xml · derivative · entry 3 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,728.539 Underlying: Common Stock · 3,728.539 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F3 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 20:13 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionRestricted Stock Units · Derivative | 15,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-009223 · doc4.xml · derivative · entry 2 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,915 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018. F2 · derivative.exercise_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018. F2 · derivative.expiration_date: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 20:13 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionCommon Stock | 15,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-009223 · doc4.xml · nonDerivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · price: Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 15,915 restricted stock units vested on March 31, 2018. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Shares · Derivative | 4,339.64 | $3.89 Strike: $3.89 | $16,876.86 |
DisclosureSEC source: 0001288123-18-000002 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339.64 Underlying: Common Stock · 4,339.64 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:29 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 4,090.589 | $4.13 Strike: $4.13 | $16,873.68 |
DisclosureSEC source: 0001288123-17-000035 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,090.589 Underlying: Common Stock · 4,090.589 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 15:23 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 4,709.928 | $3.58 Strike: $3.58 | $16,875.67 |
DisclosureSEC source: 0001288123-17-000028 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,709.928 Underlying: Common Stock · 4,709.928 shares Expires not disclosed F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:23 UTC | AGENUS INC agen · Entity 5774 | GrantStock Option, Roght to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000028 · primary_doc.xml · derivative · entry 2 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the grant date of the award or the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 20:34 UTC | AGENUS INC agen · Entity 5774 | GrantDeferred Shares · Derivative | 3,406.049 | $4.04 Strike: $4.04 | $13,750.22 |
DisclosureSEC source: 0001288123-17-000019 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,406.049 Underlying: Common Stock · 3,406.049 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 23:00 UTC | AGENUS INC agen · Entity 5774 | GrantRestricted Stock Unit · Derivative | 15,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001288123-17-000017 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,915 Underlying: Common Stock · 15,915 shares Expires 2018-03-31 F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 19:29 UTC | AGENUS INC AGEN · Entity 5774 | PurchaseCommon Stock | 30,000 | $6.29 | $188,700.00 |
DisclosureSEC source: 0001288123-16-000093 · primary_doc.xml · nonDerivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.